Simplex Trading’s Aprea Therapeutics APRE Stock Holding History

Simplex Trading’s Portfolio APRE Stock Details APRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30	Closed	-$1K	–	10311
2021 Q4	$1K	Sell	30 -1,610	-98%	-$142K	﹤0.01%	10133
2021 Q3	$177K	Buy	1,640 +575	+54%	+$52.2K	﹤0.01%	5788
2021 Q2	$103K	Buy	1,065 +1,061	+26,525%	+$98K	﹤0.01%	6685
2021 Q1	$38K	Buy	+4	New	+$467	﹤0.01%	6894

Other funds holding APRE

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Simplex Trading's APRE Position: Q2 2022 in Review

Simplex Trading sold out of Aprea Therapeutics (APRE) in Q2 2022, closing a stake of 89 shares — an estimated $2.05K sold.

Simplex Trading first reported a position in APRE in Q1 2021 and held it in 4 quarters. The position peaked at $21K in Q3 2021. 33 funds tracked by Wall St. Rank hold APRE as of Q2 2022.

Simplex Trading reported no remaining Aprea Therapeutics position as of Q2 2022 after selling out during the quarter.
Simplex Trading sold 89 Aprea Therapeutics shares in Q2 2022, an estimated $2.05K.
Simplex Trading first reported a position in Aprea Therapeutics in Q1 2021 and held it in 4 quarters.
Simplex Trading's Aprea Therapeutics position peaked at $21K in Q3 2021.
33 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.